Dihydroartemisinin Promoted Bone Marrow Mesenchymal Stem Cell Homing and Suppressed Inflammation and Oxidative Stress against Prostate Injury in Chronic Bacterial Prostatitis Mice Model
- PMID: 34956376
- PMCID: PMC8694990
- DOI: 10.1155/2021/1829736
Dihydroartemisinin Promoted Bone Marrow Mesenchymal Stem Cell Homing and Suppressed Inflammation and Oxidative Stress against Prostate Injury in Chronic Bacterial Prostatitis Mice Model
Abstract
Although bone marrow mesenchymal stem cells (BMMSCs) are effective in treating chronic bacterial prostatitis (CBP), the homing of BMMSCs seems to require ultrasound induction. Dihydroartemisinin (DHA) is an important derivative of artemisinin (ART) and has been previously reported to alleviate inflammation and autoimmune diseases. But the effect of DHA on chronic prostatitis (CP) is still unclear. This study aims to clarify the efficacy and mechanism of DHA in the treatment of CBP and its effect on the accumulation of BMMSCs. The experimental CBP was produced in C57BL/6 male mice via intraurethrally administered E. coli solution. Results showed that DHA treatment concentration-dependently promoted the accumulation of BMMSCs in prostate tissue of CBP mice. In addition, DHA and BMMSCs cotreatment significantly alleviated inflammation and improved prostate damage by decreasing the expression of proinflammatory factors such as TNF-α, IL-1β, and chemokines CXCL2, CXCL9, CXCL10, and CXCL11 in prostate tissue of CBP mice. Moreover, DHA and BMMSCs cotreatment displayed antioxidation property by increasing the production of glutathione peroxidase (GSH-Px), SOD, and decreasing malondialdehyde (MDA) expression. Mechanically, DHA and BMMSCs cotreatment significantly inhibited the expression of TGFβ-RI, TGFβ-RII, phosphor (p)-Smad2/3, and Smad4 in a dose-dependent manner while stimulated Smad7 expression in the same manner. In conclusion, our findings provided evidence that DHA effectively eliminated inflammatory and oxidative stress against prostate injury, and this effect involved the TGF-β/Smad signaling pathway in CBP.
Copyright © 2021 Shen Li et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8694990/bin/ECAM2021-1829736.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8694990/bin/ECAM2021-1829736.002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8694990/bin/ECAM2021-1829736.003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8694990/bin/ECAM2021-1829736.004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8694990/bin/ECAM2021-1829736.005.gif)
Similar articles
-
Microbubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in rats.Sci Rep. 2016 Jan 22;6:19745. doi: 10.1038/srep19745. Sci Rep. 2016. PMID: 26797392 Free PMC article.
-
Dihydroartemisinin ameliorates chronic nonbacterial prostatitis and epithelial cellular inflammation by blocking the E2F7/HIF1α pathway.Inflamm Res. 2022 Apr;71(4):449-460. doi: 10.1007/s00011-022-01544-8. Epub 2022 Mar 13. Inflamm Res. 2022. PMID: 35279736
-
[Bone marrow mesenchymal stem cells suppress E coli-induced bacterial prostatitis in rats].Zhonghua Nan Ke Xue. 2015 Apr;21(4):294-9. Zhonghua Nan Ke Xue. 2015. PMID: 26027094 Chinese.
-
MicroRNA-155 deficiency attenuates inflammation and oxidative stress in experimental autoimmune prostatitis in a TLR4-dependent manner.Kaohsiung J Med Sci. 2020 Sep;36(9):712-720. doi: 10.1002/kjm2.12229. Epub 2020 May 21. Kaohsiung J Med Sci. 2020. PMID: 32436368
-
Dihydroartemisinin ameliorated the inflammatory response and regulated miRNA-mRNA expression profile of chronic nonbacterial prostatitis.Adv Clin Exp Med. 2023 Nov 28. doi: 10.17219/acem/172386. Online ahead of print. Adv Clin Exp Med. 2023. PMID: 38014931
References
-
- Holt J. D., Garrett W. A., McCurry T. K., Teichman J. M. Common questions about chronic prostatitis. American Family Physician . 2016;93:290–296. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous